Forvis Mazars provides buy-side financial and tax due diligence services to the Eqwal Group in its acquisition of LimbTex

Our Deal Advisory Due Diligence team is delighted to announce its role in providing buy-side financial and tax due diligence services to the Eqwal Group in its successful acquisition of LimbTex.

LimbTex is a manufacturer and distributor of materials and equipment used in the production of prosthetic and orthotic devices serving UK manufacturers and the NHS while also exporting to international manufacturers.

The Eqwal Group is a healthcare and O&P patient care service provider headquartered in France and backed by Naxicap Partners.

Partner, Pierre-Paul Jacquet, commented: "We are excited to showcase the ongoing support and collaboration between Eqwal and Forvis Mazars as part of their growth strategy globally. The latest milestone now includes the successful acquisition of LimbTex in the UK."

National contacts